Protagenic Therapeutics, Inc.\new Annual Weighted Average Number of Shares Outstanding, Basic from 2014 to 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2014 to 2024.
  • Protagenic Therapeutics, Inc.\new Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 4.9M shares, a 12.8% increase year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 4.9M shares, a 12.8% increase from 2023.
  • Protagenic Therapeutics, Inc.\new annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 4.34M shares, a 0.62% increase from 2022.
  • Protagenic Therapeutics, Inc.\new annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 4.32M shares, a 17.2% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 4.9M +555K +12.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 4.34M +26.7K +0.62% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 4.32M +633K +17.2% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
2021 3.69M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2014 400M Jul 12, 2013 Jun 30, 2014 10-K 2014-10-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.